A group of international scientists from the United States and Japan discovered that aspirin helps to increase the loss of chest muscles in smokers. At the same time, drugs like statins can slow this process. The study was published in the Journal of Science on Chronic obstructive pulmonary disease (COPD).
Current and previous smokers often face the loss of skeletal muscles, especially if they have diagnosed COPD – a pneumonia, including chronic bronchitis and emphysema.
Many such patients are prescribed statin to monitor cholesterol and aspirin levels to prevent cardiovascular diseases. However, so far there has been very little data on how these drugs affect muscle mass. Scientists have analyzed data from 4191 people participating in the study of Copdgene, studying the genetic and epidemiological aspects of the holding. The patient reports the drug and provides the chest's computer -layer cutting results.
“Smokers currently and previously have higher risk of cardiovascular and diabetes, and they often prescribe statin and aspirin to treat these conditions. Researching the effects of these drugs on the region and density of the chest muscles, we found that the organs lost research, Dr. Torah Sirakhat.
According to scientists, their discovery will increase the effectiveness and safety of the treatment of patients with COPD, taking into account their lifestyle.